Mild traumatic brain injury (mTBI) is the most common form of brain trauma worldwide. The effects of mTBI are not well-studied within the elderly population, yet older adults constitute a significant portion of all mTBI patients. Few preclinical studies have focused on the effects of mTBI, or mTBI treatments, in the aged brain, and none have explored repetitive mTBI (r-mTBI). In this study, we have administered our well-characterized 5-injury model (5 r-mTBI) to hTau mice aged 24 months to explore the neurobehavioral and neuropathological outcomes, and the effects of treatment with the dihydropyridine, Nilvadipine. Our previous studies have shown that Nilvadipine inhibits spleen tyrosine kinase (Syk), is effective at reducing inflammation, tau hyperphosphorylation, and amyloid production, and it has recently been investigated in a European Phase III clinical trial for Alzheimer's disease (AD). In our 24-month-old r-mTBI mice, we observed increased neuroinflammation and a trend toward impaired cognitive performance compared to sham controls. Treatment with Nilvadipine mitigated the TBI-induced inflammatory response in aged r-mTBI animals and significantly improved spatial memory. To our knowledge, this is the only preclinical study focusing on the treatment of r-mTBI in aged, and these results suggest a therapeutic potential of Nilvadipine for consequences of mTBI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193195PMC
http://dx.doi.org/10.3389/fnagi.2018.00292DOI Listing

Publication Analysis

Top Keywords

treatment nilvadipine
8
spatial memory
8
htau mice
8
effects mtbi
8
mtbi
7
aged
5
r-mtbi
5
treatment
4
nilvadipine mitigates
4
mitigates inflammatory
4

Similar Publications

Carvedilol increases seizure resistance in a mouse model of -derived epilepsy.

Front Pharmacol

June 2024

Department of Human Genetics, Emory University, Atlanta, GA, United States.

Article Synopsis
  • - Patients with sodium channel mutations experience various symptoms, such as seizures, developmental delays, and motor issues.
  • - A study by Atkin et al. identified 90 compounds that reduced sodium influx in cells with a specific mutation, with amitriptyline, carvedilol, and nilvadipine being the most effective.
  • - In further tests on mice, amitriptyline and fenfluramine showed strong seizure protection, but only carvedilol significantly helped mice with the specific mutation, suggesting it may be a promising treatment option.
View Article and Find Full Text PDF

Nanoparticles are a boon for humanity because of their improved functionality and unlimited potential applications. Considering this significance, the proposed study introduced a simple, fast and eco-friendly method for synthesis of fluorescent silver nanoparticles (Ag-NPs) using Panax Ginseng root extract as a reducing and capping agent. Synthesis of Ag-NPs was performed in one step within three minutes utilizing microwave irradiation.

View Article and Find Full Text PDF

Purpose: Antipsychotic use in Alzheimer disease (AD) is associated with adverse events and mortality. Whilst postulated to cause/exacerbate orthostatic hypotension (OH), the exact relationship between antipsychotic use and OH has never been explored in AD-a group who are particularly vulnerable to neuro-cardiovascular instability and adverse effects of medication on orthostatic blood pressure (BP) behaviour.

Methods: We analysed longitudinal data from an 18-month trial of Nilvadipine in mild-moderate AD.

View Article and Find Full Text PDF

We investigated whether nilvadipine has a neuroprotective effect on retinal ganglion cells (RGCs) in a mouse model of ocular hypertension (OH) that expresses cyan fluorescein protein (CFP) in RGCs. OH was induced in the right eyes of Thy1-CFP transgenic mice using a laser. Nilvadipine or vehicle treatment began simultaneously with OH modeling and was administered intraperitoneally once daily for 8 weeks.

View Article and Find Full Text PDF
Article Synopsis
  • Lanosterol (LAN) has been shown to help prevent lens opacification by reversing crystalline aggregation, but it doesn't fully restore lens transparency.
  • Researchers created ophthalmic nanosuspensions (LAN-ONSs and NIL-ONSs) using LAN and nilvadipine (NIL) to target cataract-related factors, testing their combined effect on cataractic rats.
  • The combination of LAN-ONSs and NIL-ONSs significantly reduced cataract symptoms, such as calcium and calpain levels, and improved lens opacity, suggesting potential for future cataract treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!